Savara, Inc. (SVRA)
5.22
-0.05
(-0.95%)
USD |
NASDAQ |
May 07, 09:44
Savara Free Cash Flow : -101.06M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Spyre Therapeutics, Inc. | -185.87M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Imunon, Inc. | -14.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.06M |
| Cash from Investing (Quarterly) | -93.56M |
| Cash from Financing (Quarterly) | 135.56M |
| Free Cash Flow Per Share (Quarterly) | -0.1043 |
| Free Cash Flow to Equity (Quarterly) | -25.14M |
| Free Cash Flow to Firm (Quarterly) | -25.06M |
| Free Cash Flow Yield | -8.71% |